ArticleFrontiers in cardiovascular medicine2025
Global trends in ambient particulate matter-attributable ischemic heart disease among the elderly (1990-2021).
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Airborne particulate matter (PM), particularly PM₂.₅, poses a growing threat to cardiovascular health, especially among older adults. With intensified urbanization and industrial activities, PM₂.₅ has become a major factor contributing to ischemic heart disease (IHD), a leading cause of global mortality. These fine particles can penetrate pulmonary defenses, enter circulation, and trigger inflammatory and oxidative pathways that accelerate vascular damage. The elderly, whose physiological resilience declines with age, are particularly susceptible. While PM exposure's link to IHD is established, patterns by sex and age in older populations remain underexplored. This study assesses global, regional, and national shifts in PM-related IHD burden between 1990 and 2021, identifies disparities across demographics, and examines the influence of socioeconomic development. It also forecasts trends to 2040, providing insights to guide public health interventions for aging societies. Methods: Using the Global Burden of Disease study (GBD 2021), we analyzed mortality and disability-adjusted life years (DALYs) from 1990 to 2021 across global, regional, and national levels. We calculated age-standardized rates (ASRs) and estimated annual percentage changes (EAPCs). Future trends were projected using a Bayesian age-period-cohort (BAPC) model. Modelling was performed in R, disaggregated by sex and age, linked with PM exposure and socioeconomic development. Results: Overall IHD due to PM declined globally from 1990 to 2021. The largest reductions occurred in high-SDI regions. Burden increased in low- and middle-income areas in Asia and Africa. Globally, IHD burden from PM was negatively correlated with sociodemographic index (SDI). Men had higher burdens than women, with differences increasing by age. Although BAPC projections indicate a continued decline, a potential rise in pollution around 2035 may slow the rate of decrease or temporarily flatten the downward trajectory. Conclusion: Although global declines have been observed, the burden of ischemic heart disease (IHD) attributable to ambient particulate matter pollution remains persistently high in Southeast Asia and Africa. Forecasts suggest that elderly individuals, particularly men, will continue to experience disproportionate health impacts in the coming decades. Targeted public health initiatives focused on reducing particulate matter exposure, especially among vulnerable aging populations, are essential to mitigate future cardiovascular risks and promote healthy aging worldwide.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.